Evrysdi Prescription Drug (Genentech) – Packaging Issue (2021)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Consumer Product Safety Commission (CPSC)
Product
Evrysdi™ (risdiplam)
Brand
Genentech, a member of the Roche Group, of South San Francisco, Calif.
Lot Codes / Batch Numbers
Not specified in CPSC notice. Check official source for details.
Product Images
Source: U.S. Consumer Product Safety Commission
Genentech, a member of the Roche Group, of South San Francisco, Calif. is recalling Evrysdi™ (risdiplam). The hazard is: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle. Based on CPSC recall notice.
Summary derived from CPSC notice
The following details were not provided by CPSC: UPC codes.
Reason for Recall
As stated by CPSC
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Reported concern (CPSC)
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Recommended Action
Per CPSC guidance
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Verify this information on the official source
For complete details and official instructions, check the U.S. Consumer Product Safety Commission (CPSC) directly.
View official CPSC recall noticePage updated: Jan 10, 2026